• Mon news: Autolus enters CAR-T race with FDA approval. FDA clears clinical hold on Novavax. AbbVie schizophrenia trial failure. Cigna not pursuing Humana. GSK leaving BIO. See more on our front page

Takeda gives Sun Pharma, Cipla rights to commercialize gastro drug in India

cafead

Administrator
Staff member
  • cafead   Jun 21, 2024 at 11:22: AM
via Japan's Takeda Pharmaceutical (4502.T) gave India's Sun Pharmaceutical (SUN.NS) and Cipla (CIPL.NS) the rights to commercialize gastrointestinal drug Vonoprazan in the country.

article source